Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-12.33	55.50	63.31
Graham Fair Price	28.18	12.94	10.09
PEG	-55.16	0.36	-0.81
Price/Book	-3.36	6.21	6.43
Price/Cash Flow	52.80	92.76	60.71
Prices/Earnings	-24.72	15.93	21.16
Price/Sales	0.01	8.38	8.38
Price/FCF	52.80	92.76	60.71
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.68	0.32	0.31
Operating Margin	11.98	0.13	0.12
ROA	35.95	0.05	0.04
ROE	0.08	0.10	28.37
ROIC	0.06	0.06	10.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.17	-0.16	4.21
Dividends QOQ	0.12	-0.30	152.11
EBIT QOQ	-0.21	0.22	6.67
EPS QOQ	-0.26	0.44	67.88
FCF QOQ	1.01	-0.28	-71.84
Revenue QOQ	< 0.005	0.09	117614.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	69.88	60.92	-12.82
Days Sales Outstanding (DSO)	30.14	15.90	-47.24
Inventory Turnover	1.29	1.48	14.71
Debt/Capitalization	0.27	0.27	0.33
Quick Ratio	0.50	0.51	2.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.72	8.73	13.13
Cash	1.66	2.58	55.70
Capex	-0.42	-0.56	-32.72
Free Cash Flow	0.82	0.58	-28.45
Revenue	5.92	6.48	9.31
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.95	1.05	10.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.56	0.82	-47.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating